Stammdaten
Twist Bioscience Corporation, ein Synthetic-Biology-Unternehmen, stellt synthetische DNA-basierte Produkte her und verkauft diese. Die DNA-Syntheseplattform des Unternehmens ermöglicht die Herstellung von synthetischer DNA durch das Schreiben von DNA auf einen Siliziumchip. Es bietet synthetische DNA-basierte Produkte an, einschließlich synthetischer Gene, Werkzeuge zur Probenvorbereitung, Antikörper-Bibliotheken für die Arzneistoff-Entdeckung und -Entwicklung sowie DNA als digitales Datenspeichermedium. Das Unternehmen hat Kooperationsvereinbarungen mit Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; und Centogene N.V zur Entwicklung fortgeschrittener Sequenzierungswerkzeuge. Es hat auch eine Forschungskooperation mit Boehringer Ingelheim International GmbH, um proprietäre Antikörper-Bibliotheken zur Entdeckung therapeutischer Antikörper gegen mehrere Ziele zu nutzen. Twist Bioscience Corporation wurde 2013 gegründet und hat seinen Sitz in South San Francisco, Kalifornien.
Unternehmen & Branche
| Name | Twist Bioscience Corp |
|---|---|
| Ticker | TWST |
| CIK | 0001581280 |
| Börse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 90184D100 |
|---|---|
| ISIN | US90184D1000 |
| Typ | Common Stock |
| Marktkapitalisierung | 5,50 Mrd. USD |
| Beta | 2,18 |
Sitz & Kontakt
| Sitz (Inkorporation) | DE |
|---|---|
| Geschäftsadresse | 681 GATEWAY BLVD., 94080 SOUTH SAN FRANCISCO, CA |
| Telefon | 800-719-0671 |
| EIN (IRS) | 46-2058888 |
Listing & Historie
| Listing-Börsen | Nasdaq |
|---|---|
| Fiskaljahr-Ende | 30.09. |
| SEC-Filer-Status | Large accelerated filer |
Bewertung
| KBV (P/B) | 11,62 vs. 9,12 (2021) ▲ |
|---|---|
| FCF-Rendite | -1,4 % vs. -2,6 % (2021) ▲ |
Qualität & Bilanz
| ROIC | -14,2 % vs. -23,6 % (2021) ▲ |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 30.09.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|---|---|
| Bewertung | |||||||
| KBV (P/B) | 9,12 | 2,52 | 1,87 | 5,63 | 3,61 | 12,08 | |
| FCF-Rendite | -2,6 % | -11,4 % | -14,6 % | -2,6 % | -4,4 % | -1,7 % | |
| Qualität & Bilanz | |||||||
| ROIC | -23,6 % | -24,6 % | -28,5 % | -37,4 % | -14,2 % | -14,8 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
ⓘ
TWST
Twist Bioscience Corp
ⓘ
Eingeschränkte Aussagekraft — erst 61 % der Signal-Gewichte sind mit Daten unterlegt.
Effektiv
Risiko-Ausstieg
Handelsvolumen
Hoch
Insider
0,0
Keine Insider-Käufe
Institutionell
41,1
65 neu, 76 erhöht, 980,4M $ netto
Aktivist
10,6
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,71% (Stand: 30.06.2026)
Score-Verlauf (90 Tage)
Konviktions-Verlauf — oben stark · Mitte neutral · unten schwach
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 72.85 | +24.4 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 47.98 | +88.9 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 89.29 | EMA50: 77.22 | |
| MACD-Histogramm | Bärisch | 10 % | -1.459 | Bearisch | |
| RSI(14) | Neutral | 10 % | 55.7 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 38.0 | Neutral | |
| ADX(14)+DI | Bullisch | 10 % | 46.4 | +DI: 27.4 / −DI: 17.2 | |
| Z-Score(60) | Neutral | 5 % | 1.27 | In Range | |
| 52W-Position | Bullisch | 5 % | 84.5 % | Hoch 102.88 / Tief 24.16 | |
| Bollinger(20,2σ) | Neutral | 5 % | 50.2 % | Upper 107.22 / Mid 90.59 / Lower 73.96 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.7829 | R²=0.75 / annualisiert +278.9 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -2.399 | 94,33 | -226.307,27 | -98,6% | |
| 2026-06-25 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -18.880 | 95,00 | -1.793.600,00 | -781,3% | |
| 2026-06-24 | Cho Dennis | Officer, See Remarks | Open Market Sale | -14.205 | 89,75 | -1.274.898,75 | -555,4% | |
| 2026-06-22 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -291 | 87,32 | -25.410,82 | -11,1% | |
| 2026-06-22 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -1.688 | 87,32 | -147.400,21 | -64,2% | |
| 2026-06-22 | Cho Dennis | Officer, See Remarks | Open Market Sale | -346 | 87,32 | -30.213,55 | -13,2% | |
| 2026-06-15 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -24.109 | 81,62 | -1.967.856,14 | -857,2% | |
| 2026-06-15 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -2.028 | 82,17 | -166.631,63 | -72,6% | |
| 2026-06-08 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -232 | 69,84 | -16.203,85 | -7,1% | |
| 2026-06-08 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -884 | 69,84 | -61.742,27 | -26,9% | |
| 2026-06-08 | Cho Dennis | Officer, See Remarks | Open Market Sale | -402 | 69,84 | -28.077,37 | -12,2% | |
| 2026-06-08 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -1.127 | 69,07 | -77.841,89 | -33,9% | |
| 2026-06-08 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -2.265 | 69,84 | -158.197,11 | -68,9% | |
| 2026-05-29 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -4.000 | 70,00 | -280.000,00 | -122,0% | |
| 2026-05-29 | Cho Dennis | Officer, See Remarks | Open Market Sale | -14.205 | 69,75 | -990.798,75 | -431,6% | |
| 2026-05-28 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -1.482 | 65,33 | -96.812,54 | -42,2% | |
| 2026-05-28 | Starovasnik Melissa A. | Director | Open Market Sale | -2.500 | 68,00 | -170.000,00 | -74,1% | |
| 2026-05-28 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -7.623 | 67,95 | -517.988,95 | -225,6% | |
| 2026-05-28 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -6.465 | 68,61 | -443.590,16 | -193,2% | |
| 2026-05-28 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -900 | 66,85 | -60.162,93 | -26,2% | |
| 2026-05-27 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -1.265 | 66,28 | -83.845,84 | -36,5% | |
| 2026-05-27 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -23.752 | 65,24 | -1.549.561,48 | -675,0% | |
| 2026-05-26 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -800 | 62,48 | -49.987,20 | -21,8% | |
| 2026-05-26 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -24.282 | 65,08 | -1.580.245,85 | -688,4% | |
| 2026-05-26 | Starovasnik Melissa A. | Director | Open Market Sale | -500 | 61,04 | -30.520,00 | -13,3% | |
| 2026-05-21 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -1.399 | 53,26 | -74.506,54 | -32,5% | |
| 2026-05-21 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -2.019 | 53,26 | -107.525,88 | -46,8% | |
| 2026-05-21 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -6.888 | 53,26 | -366.834,22 | -159,8% | |
| 2026-05-21 | Cho Dennis | Officer, See Remarks | Open Market Sale | -1.642 | 53,26 | -87.447,99 | -38,1% | |
| 2026-05-21 | Finn Patrick John | Officer, President and COO | Open Market Sale | -4.160 | 53,26 | -221.549,12 | -96,5% | |
| 2026-05-21 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -688 | 53,26 | -36.640,82 | -16,0% | |
| 2026-05-12 | JOHANNESSEN JAN | Director | Open Market Sale | -12.000 | 56,12 | -673.440,00 | -293,4% | |
| 2026-05-08 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -4.961 | 56,88 | -282.186,64 | -122,9% | |
| 2026-05-04 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -1.116 | 57,15 | -63.778,06 | -27,8% | |
| 2026-05-04 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -164 | 57,15 | -9.372,40 | -4,1% | |
| 2026-05-04 | Finn Patrick John | Officer, President and COO | Open Market Sale | -2.844 | 57,15 | -162.531,19 | -70,8% | |
| 2026-05-04 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -5.127 | 57,15 | -293.001,90 | -127,6% | |
| 2026-05-04 | Cho Dennis | Officer, See Remarks | Open Market Sale | -1.962 | 57,15 | -112.125,95 | -48,8% | |
| 2026-04-27 | Starovasnik Melissa A. | Director | Open Market Sale | -500 | 61,83 | -30.915,00 | -13,5% | |
| 2026-04-23 | Finn Patrick John | Officer, President and COO | Open Market Sale | -2.321 | 60,76 | -141.026,28 | -61,4% | |
| 2026-04-22 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -7.910 | 65,28 | -516.325,25 | -224,9% | |
| 2026-04-22 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -151 | 66,00 | -9.966,00 | -4,3% | |
| 2026-04-21 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -1.610 | 65,01 | -104.666,10 | -45,6% | |
| 2026-04-17 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -4.000 | 60,00 | -240.000,00 | -104,5% | |
| 2026-04-14 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -3.000 | 55,00 | -165.000,00 | -71,9% | |
| 2026-04-09 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -2.597 | 49,89 | -129.561,73 | -56,4% | |
| 2026-04-01 | Starovasnik Melissa A. | Director | Open Market Sale | -1.000 | 51,00 | -51.000,00 | -22,2% | |
| 2026-03-20 | Cho Dennis | Officer, See Remarks | Open Market Sale | -354 | 43,79 | -15.500,39 | -6,8% | |
| 2026-03-20 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -1.742 | 43,79 | -76.275,91 | -33,2% | |
| 2026-03-20 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -297 | 43,79 | -13.004,56 | -5,7% | |
| 2026-03-17 | CHESS ROBERT | Director | Open Market Sale | -10.000 | 47,00 | -470.000,00 | -204,7% | |
| 2026-03-06 | Cho Dennis | Officer, See Remarks | Open Market Sale | -425 | 46,43 | -19.731,05 | -8,6% | |
| 2026-03-06 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -2.423 | 46,43 | -112.490,20 | -49,0% | |
| 2026-03-06 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -935 | 46,43 | -43.408,31 | -18,9% | |
| 2026-03-06 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -246 | 46,43 | -11.420,80 | -5,0% | |
| 2026-02-23 | Cho Dennis | Officer, See Remarks | Open Market Sale | -844 | 46,71 | -39.423,07 | -17,2% | |
| 2026-02-23 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -2.085 | 46,71 | -97.389,93 | -42,4% | |
| 2026-02-23 | Finn Patrick John | Officer, President and COO | Open Market Sale | -4.294 | 46,71 | -200.571,88 | -87,4% | |
| 2026-02-23 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -7.205 | 46,71 | -336.544,11 | -146,6% | |
| 2026-02-23 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -1.465 | 46,71 | -68.429,86 | -29,8% | |
| 2026-02-23 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -1.693 | 46,71 | -79.079,69 | -34,4% | |
| 2026-02-17 | Finn Patrick John | Officer, President and COO | Open Market Sale | -3.541 | 53,11 | -188.062,51 | -81,9% | |
| 2026-02-17 | Finn Patrick John | Officer, President and COO | Open Market Sale | -26.952 | 52,69 | -1.419.993,07 | -618,6% | |
| 2026-02-17 | Finn Patrick John | Officer, President and COO | Open Market Sale | -21.858 | 50,32 | -1.099.916,42 | -479,1% | |
| 2026-02-17 | Finn Patrick John | Officer, President and COO | Open Market Sale | -16.616 | 51,42 | -854.444,57 | -372,2% | |
| 2026-02-17 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -39.404 | 52,40 | -2.064.769,60 | -899,5% | |
| 2026-02-13 | Finn Patrick John | Officer, President and COO | Open Market Sale | -1.750 | 50,04 | -87.571,75 | -38,1% | |
| 2026-02-13 | CHESS ROBERT | Director | Open Market Sale | -2.184 | 48,26 | -105.402,02 | -45,9% | |
| 2026-02-12 | Finn Patrick John | Officer, President and COO | Open Market Sale | -3.500 | 50,23 | -175.787,50 | -76,6% | |
| 2026-02-12 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -7.000 | 50,00 | -350.000,00 | -152,5% | |
| 2026-02-11 | Cho Dennis | Officer, See Remarks | Open Market Sale | -5.000 | 49,93 | -249.650,00 | -108,8% | |
| 2026-02-06 | JOHANNESSEN JAN | Director | Open Market Sale | -2.200 | 47,91 | -105.394,74 | -45,9% | |
| 2026-02-04 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -7.000 | 45,65 | -319.536,00 | -139,2% | |
| 2026-02-03 | Finn Patrick John | Officer, President and COO | Open Market Sale | -2.705 | 46,58 | -125.988,08 | -54,9% | |
| 2026-02-03 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -5.001 | 46,58 | -232.926,58 | -101,5% | |
| 2026-02-03 | Cho Dennis | Officer, See Remarks | Open Market Sale | -1.099 | 46,58 | -51.187,02 | -22,3% | |
| 2026-02-03 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -175 | 46,58 | -8.150,80 | -3,6% | |
| 2026-02-03 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -1.194 | 46,58 | -55.611,74 | -24,2% | |
| 2026-01-23 | Finn Patrick John | Officer, President and COO | Open Market Sale | -2.390 | 44,91 | -107.330,12 | -46,8% | |
| 2026-01-13 | Finn Patrick John | Officer, President and COO | Open Market Sale | -23.279 | 40,00 | -931.160,00 | -405,6% | |
| 2026-01-13 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -3.000 | 40,00 | -120.000,00 | -52,3% | |
| 2026-01-09 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -2.738 | 35,26 | -96.544,62 | -42,1% | |
| 2025-12-22 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -273 | 34,56 | -9.433,79 | -4,1% | |
| 2025-12-22 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -1.605 | 34,56 | -55.462,38 | -24,2% | |
| 2025-12-22 | Cho Dennis | Officer, See Remarks | Open Market Sale | -324 | 34,56 | -11.196,14 | -4,9% | |
| 2025-12-08 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -230 | 32,88 | -7.561,94 | -3,3% | |
| 2025-12-08 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -2.255 | 32,88 | -74.139,89 | -32,3% | |
| 2025-12-08 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -877 | 32,88 | -28.834,01 | -12,6% | |
| 2025-12-08 | Cho Dennis | Officer, See Remarks | Open Market Sale | -398 | 32,88 | -13.085,44 | -5,7% | |
| 2025-11-24 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -822 | 28,71 | -23.599,21 | -10,3% | |
| 2025-11-21 | Cho Dennis | Officer, See Remarks | Open Market Sale | -757 | 26,50 | -20.063,15 | -8,7% | |
| 2025-11-21 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -229 | 26,50 | -6.069,30 | -2,6% | |
| 2025-11-21 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -887 | 26,50 | -23.508,60 | -10,2% | |
| 2025-11-21 | Finn Patrick John | Officer, President and COO | Open Market Sale | -1.776 | 26,50 | -47.070,22 | -20,5% | |
| 2025-11-21 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -2.663 | 26,50 | -70.578,82 | -30,7% | |
| 2025-11-21 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -598 | 26,50 | -15.849,09 | -6,9% | |
| 2025-11-18 | JOHANNESSEN JAN | Director | Open Market Sale | -7.044 | 24,77 | -174.479,88 | -76,0% | |
| 2025-11-03 | Cho Dennis | Officer, See Remarks | Open Market Sale | -1.019 | 32,08 | -32.688,91 | -14,2% | |
| 2025-11-03 | Finn Patrick John | Officer, President and COO | Open Market Sale | -2.755 | 32,08 | -88.378,75 | -38,5% | |
| 2025-11-03 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -4.887 | 32,08 | -156.772,03 | -68,3% | |
| 2025-11-03 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -1.084 | 32,08 | -34.774,07 | -15,1% | |
| 2025-11-03 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -160 | 32,08 | -5.132,70 | -2,2% | |
| 2025-10-30 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -6.920 | 31,44 | -217.594,56 | -94,8% | |
| 2025-10-30 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -5.517 | 31,44 | -173.478,20 | -75,6% | |
| 2025-10-30 | Finn Patrick John | Officer, President and COO | Open Market Sale | -17.606 | 31,44 | -553.608,35 | -241,2% | |
| 2025-10-30 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -31.379 | 31,44 | -986.690,69 | -429,8% | |
| 2025-10-30 | Cho Dennis | Officer, See Remarks | Open Market Sale | -6.515 | 31,44 | -204.859,61 | -89,2% | |
| 2025-10-30 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -1.016 | 31,44 | -31.947,41 | -13,9% | |
| 2025-10-23 | Finn Patrick John | Officer, President and COO | Open Market Sale | -2.240 | 30,88 | -69.160,00 | -30,1% | |
| 2025-10-09 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -2.517 | 32,92 | -82.864,67 | -36,1% | |
| 2025-10-08 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -3.000 | 31,15 | -93.450,00 | -40,7% | |
| 2025-10-06 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -31.348 | 32,19 | -1.008.998,08 | -439,5% | |
| 2025-10-06 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -9.724 | 32,19 | -312.986,39 | -136,3% | |
| 2025-10-06 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -2.041 | 32,19 | -65.693,67 | -28,6% | |
| 2025-10-06 | Cho Dennis | Officer, See Remarks | Open Market Sale | -3.876 | 32,19 | -124.756,81 | -54,3% | |
| 2025-10-06 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -5.875 | 32,19 | -189.098,63 | -82,4% | |
| 2025-10-06 | Finn Patrick John | Officer, President and COO | Open Market Sale | -23.747 | 32,19 | -764.344,69 | -333,0% | |
| 2025-10-02 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -140 | 29,16 | -4.082,54 | -1,8% | |
| 2025-10-02 | Finn Patrick John | Officer, President and COO | Open Market Sale | -206 | 29,16 | -6.007,17 | -2,6% | |
| 2025-10-02 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -476 | 29,16 | -13.880,64 | -6,0% | |
| 2025-10-02 | Cho Dennis | Officer, See Remarks | Open Market Sale | -124 | 29,16 | -3.615,96 | -1,6% | |
| 2025-09-22 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -295 | 27,56 | -8.130,20 | -3,5% | |
| 2025-09-22 | Cho Dennis | Officer, See Remarks | Open Market Sale | -233 | 27,56 | -6.421,48 | -2,8% | |
| 2025-09-22 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -1.704 | 27,56 | -46.962,24 | -20,5% | |
| 2025-09-15 | Cho Dennis | Officer, See Remarks | Open Market Sale | -94 | 25,33 | -2.380,83 | -1,0% | |
| 2025-09-08 | Cho Dennis | Officer, See Remarks | Open Market Sale | -269 | 25,76 | -6.929,44 | -3,0% | |
| 2025-09-08 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -235 | 25,76 | -6.053,60 | -2,6% | |
| 2025-09-08 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -2.265 | 25,76 | -58.346,40 | -25,4% | |
| 2025-09-08 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -892 | 25,76 | -22.977,92 | -10,0% | |
| 2025-08-25 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -853 | 27,69 | -23.620,42 | -10,3% | |
| 2025-08-21 | Cho Dennis | Officer, See Remarks | Open Market Sale | -521 | 25,96 | -13.527,24 | -5,9% | |
| 2025-08-21 | Laponis Adam | Officer, Chief Financial Officer | Open Market Sale | -918 | 25,96 | -23.834,95 | -10,4% | |
| 2025-08-21 | Finn Patrick John | Officer, President and COO | Open Market Sale | -1.840 | 25,96 | -47.773,76 | -20,8% | |
| 2025-08-21 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -2.716 | 25,96 | -70.518,22 | -30,7% | |
| 2025-08-21 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -619 | 25,96 | -16.071,72 | -7,0% | |
| 2025-08-21 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -238 | 25,96 | -6.179,43 | -2,7% | |
| 2025-08-04 | Cho Dennis | Officer, See Remarks | Open Market Sale | -785 | 28,36 | -22.265,74 | -9,7% | |
| 2025-08-04 | Finn Patrick John | Officer, President and COO | Open Market Sale | -3.189 | 28,36 | -90.452,80 | -39,4% | |
| 2025-08-04 | Leproust Emily M. | Director, Officer, Chief Executive Officer | Open Market Sale | -5.585 | 28,36 | -158.412,94 | -69,0% | |
| 2025-08-04 | Green Paula | Officer, SVP of Human Resources | Open Market Sale | -1.255 | 28,36 | -35.596,82 | -15,5% | |
| 2025-08-04 | WERNER ROBERT F. | Officer, Chief Accounting Officer | Open Market Sale | -186 | 28,36 | -5.275,70 | -2,3% | |
| 2025-07-23 | Finn Patrick John | Officer, President and COO | Open Market Sale | -2.232 | 35,74 | -79.773,91 | -34,8% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 673 von typischerweise 8343 Fonds (8 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Artisan Partners Limited Partnership | 6.367.777 | 0 | 6.367.777 | 302.596.753 | Neu | +100,0% | |
| ARK Investment Management LLC | 6.342.733 | 0 | 6.342.733 | 301.406.681 | Neu | +100,0% | |
| BlackRock, Inc. | 5.554.362 | 0 | 5.554.362 | 263.943.282 | Neu | +100,0% | |
| EdgePoint Investment Group Inc. | 5.382.521 | 0 | 5.382.521 | 255.777.398 | Neu | +100,0% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 5.269.718 | 0 | 5.269.718 | 250.416.999 | Neu | +100,0% | |
| STATE STREET CORP | 3.670.682 | 0 | 3.670.682 | 174.430.809 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.639.044 | 0 | 2.639.044 | 125.407.371 | Neu | +100,0% | |
| Invesco Ltd. | 2.171.898 | 0 | 2.171.898 | 103.208.593 | Neu | +100,0% | |
| FMR LLC | 1.889.945 | 0 | 1.889.945 | 89.810.193 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1.705.546 | 0 | 1.705.546 | 81.047.546 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.519.713 | 0 | 1.519.713 | 72.230.837 | Neu | +100,0% | |
| Amova Asset Management Americas, Inc. | 1.496.099 | 0 | 1.496.099 | 71.094.624 | Neu | +100,0% | |
| Sumitomo Mitsui Trust Group, Inc. | 1.496.099 | 0 | 1.496.099 | 71.094.624 | Neu | +100,0% | |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1.427.650 | 0 | 1.427.650 | 67.841.928 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 1.329.900 | 0 | 1.329.900 | 63.196.848 | Neu | +100,0% | |
| Soleus Capital Management, L.P. | 1.226.629 | 0 | 1.226.629 | 58.289.410 | Neu | +100,0% | |
| BAILLIE GIFFORD & CO | 1.215.151 | 0 | 1.215.151 | 57.743.975 | Neu | +100,0% | |
| First Light Asset Management, LLC | 878.848 | 0 | 878.848 | 41.762.857 | Neu | +100,0% | |
| Tao Capital Management LP | 828.815 | 0 | 828.815 | 39.385.289 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 823.976 | 0 | 823.976 | 39.155.339 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 781.618 | 0 | 781.618 | 37.128.685 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 738.629 | 0 | 738.629 | 35.099.650 | Neu | +100,0% | |
| BALYASNY ASSET MANAGEMENT L.P. | 726.288 | 0 | 726.288 | 34.513.206 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 691.363 | 0 | 691.363 | 32.853.570 | Neu | +100,0% | |
| NEW YORK STATE COMMON RETIREMENT FUND | 673.987 | 0 | 673.987 | 32.027.862 | Neu | +100,0% | |
| Point72 Asset Management, L.P. | 669.732 | 0 | 669.732 | 31.825.665 | Neu | +100,0% | |
| JENNISON ASSOCIATES LLC | 605.188 | 0 | 605.188 | 28.758.535 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 604.047 | 0 | 604.047 | 28.704.313 | Neu | +100,0% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 584.696 | 0 | 584.696 | 27.784.754 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 584.261 | 0 | 584.261 | 27.764.083 | Neu | +100,0% | |
| MORGAN STANLEY | 546.845 | 0 | 546.845 | 25.986.121 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 537.111 | 0 | 537.111 | 25.523.515 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 527.966 | 0 | 527.966 | 25.088.945 | Neu | +100,0% | |
| LOOMIS SAYLES & CO L P | 492.290 | 0 | 492.290 | 23.393.621 | Neu | +100,0% | |
| Allspring Global Investments Holdings, LLC | 455.446 | 0 | 455.446 | 22.562.795 | Neu | +100,0% | |
| CITIGROUP INC | 460.287 | 0 | 460.287 | 21.872.838 | Neu | +100,0% | |
| UBS Group AG | 452.526 | 0 | 452.526 | 21.504.035 | Neu | +100,0% | |
| SEI INVESTMENTS CO | 354.420 | 0 | 354.420 | 16.842.064 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 350.604 | 0 | 350.604 | 16.660.702 | Neu | +100,0% | |
| Holocene Advisors, LP | 344.758 | 0 | 344.758 | 16.382.900 | Neu | +100,0% | |
| Nuveen, LLC | 293.655 | 0 | 293.655 | 13.954.485 | Neu | +100,0% | |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 284.589 | 0 | 284.589 | 13.523.669 | Neu | +100,0% | |
| Blue Water Life Science Advisors, LP | 276.000 | 0 | 276.000 | 13.115.520 | Neu | +100,0% | |
| Freshford Capital Management, LLC | 258.982 | 0 | 258.982 | 12.306.824 | Neu | +100,0% | |
| Schonfeld Strategic Advisors LLC | 258.604 | 0 | 258.604 | 12.288.860 | Neu | +100,0% | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 244.025 | 0 | 244.025 | 11.596.068 | Neu | +100,0% | |
| Meridiem Capital Partners LP | 239.669 | 0 | 239.669 | 11.389.071 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 227.719 | 0 | 227.719 | 10.821.207 | Neu | +100,0% | |
| PEREGRINE CAPITAL MANAGEMENT LLC | 220.079 | 0 | 220.079 | 10.458.154 | Neu | +100,0% | |
| OSTERWEIS CAPITAL MANAGEMENT INC | 211.158 | 0 | 211.158 | 10.034.228 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 673 von typischerweise 8343 Fonds (8 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| MOODY NATIONAL BANK TRUST DIVISION | 20.316 | 0 | +100,0% | 2.090.110 | 56,27 | 1 % | 1 Q |
| E. Ohman J:or Asset Management AB | 8.287 | 0 | +100,0% | 852.567 | 22,95 | 100 % | 1 Q |
| SteelPeak Wealth, LLC | 5.677 | 19.537 | -70,9% | 584.050 | 15,72 | 51 % | 11 Q |
| GAMMA Investing LLC | 943 | 758 | +24,4% | 97.016 | 2,61 | 100 % | 11 Q |
| Ares Financial Consulting, LLC | 497 | 497 | 0,0% | 51.131 | 1,38 | 100 % | 2 Q |
| Versant Capital Management, Inc | 289 | 287 | +0,7% | 29.732 | 0,80 | 100 % | 13 Q |
| Torren Management, LLC | 70 | 70 | 0,0% | 7.202 | 0,19 | 0 % | 3 Q |
| Handelsbanken Fonder AB | 25.000 | 25.000 | 0,0% | 2.572 | 0,07 | 0 % | 9 Q |
| MassMutual Private Wealth & Trust, FSB | 3 | 0 | +100,0% | 309 | 0,01 | 100 % | 5 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 9 | 0,1 | 4 |
| 31.03.2026 | ✓ | 276 | 79,7 | 3.700 |
| 31.12.2025 | ✓ | 239 | 77,5 | 2.398 |
| 30.09.2025 | ✓ | 237 | 76,7 | 2.115 |
| 30.06.2025 | ✓ | 238 | 71,9 | 3.580 |
| 31.03.2025 | ✓ | 259 | 75,4 | 2.813 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 2.639.044 | 125.407.371 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1.427.650 | 67.841.928 |
| Point72 Asset Management, L.P. | 669.732 | 31.825.665 |
| JANE STREET GROUP, LLC | 601.163 | 28.567.266 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 584.696 | 27.784.754 |
| LOOMIS SAYLES & CO L P | 492.290 | 23.393.621 |
| Allspring Global Investments Holdings, LLC | 455.446 | 22.562.795 |
| Holocene Advisors, LP | 344.758 | 16.382.900 |
| PERCEPTIVE ADVISORS LLC | 150.000 | 7.128.000 |
| PRINCIPAL FINANCIAL GROUP INC | 106.712 | 5.070.954 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| FMR LLC | 1.889.945 | 1.821.008 | +2641.6 % | 89.810.193 |
| CITADEL ADVISORS LLC | 1.220.400 | 1.188.351 | +3707.9 % | 57.993.408 |
| Invesco Ltd. | 2.171.898 | 881.627 | +68.3 % | 103.208.593 |
| Artisan Partners Limited Partnership | 6.367.777 | 537.572 | +9.2 % | 302.596.753 |
| Meridiem Capital Partners LP | 239.669 | 218.464 | +1030.2 % | 11.389.071 |
| BNP PARIBAS FINANCIAL MARKETS | 604.047 | 188.438 | +45.3 % | 28.704.313 |
| BANK OF AMERICA CORP /DE/ | 584.261 | 184.907 | +46.3 % | 27.764.083 |
| BALYASNY ASSET MANAGEMENT L.P. | 726.288 | 146.918 | +25.4 % | 34.513.206 |
| Schonfeld Strategic Advisors LLC | 258.604 | 118.711 | +84.9 % | 12.288.860 |
| Squarepoint Ops LLC | 153.526 | 117.809 | +329.8 % | 7.295.556 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| ARK Investment Management LLC | 6.342.733 | -1.216.762 | -16.1 % | 301.406.681 |
| MILLENNIUM MANAGEMENT LLC | 350.604 | -1.147.142 | -76.6 % | 16.660.702 |
| AMERICAN CENTURY COMPANIES INC | 37.838 | -827.796 | -95.6 % | 1.798.070 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 5.269.718 | -684.711 | -11.5 % | 250.416.999 |
| Soleus Capital Management, L.P. | 1.226.629 | -635.173 | -34.1 % | 58.289.410 |
| STEMPOINT CAPITAL LP | 43.110 | -475.245 | -91.7 % | 2.048.587 |
| Sumitomo Mitsui Trust Group, Inc. | 1.496.099 | -406.730 | -21.4 % | 71.094.624 |
| Amova Asset Management Americas, Inc. | 1.496.099 | -406.730 | -21.4 % | 71.094.624 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 823.976 | -349.124 | -29.8 % | 39.155.339 |
| BlackRock, Inc. | 5.554.362 | -340.610 | -5.8 % | 263.943.282 |
Zusätzlich aktuell von 140 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Δ-Balken |
|---|---|---|---|---|---|---|
| 07.05.2026 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | Passiv (13G/A) | 8,60 % | 5.269.718 | -1,10 pp | |
| 30.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,05 % | 3.101.909 | Neu | |
| 30.04.2026 | ARK Investment Management LLC (+1) | Passiv (13G/A) | 10,35 % | 6.342.733 | -2,01 pp | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -9,49 pp | |
| 06.03.2026 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 10,10 % | 6.217.213 | +0,60 pp | |
| 17.02.2026 | EdgePoint Investment Group Inc. | Passiv (13G/A) | 8,80 % | 5.377.991 | +2,04 pp | |
| 09.02.2026 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | Passiv (13G/A) | 9,70 % | 5.954.429 | +3,30 pp | |
| 03.02.2026 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 9,50 % | 5.830.205 | -1,10 pp | |
| 03.02.2026 | ARK Investment Management LLC (+1) | Passiv (13G/A) | 12,36 % | 7.559.495 | +1,66 pp | |
| 14.11.2025 | EdgePoint Investment Group Inc. | Passiv (13G) | 6,76 % | 4.082.319 | Neu | |
| 10.11.2025 | STATE STREET CORPORATION | Passiv (13G) | 5,10 % | 3.089.063 | +0,80 pp | |
| 07.10.2025 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 10,60 % | 6.410.900 | +2,20 pp | |
| 12.08.2025 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 8,40 % | 5.061.033 | Neu | |
| 07.08.2025 | Invesco Ltd. | Passiv (13G/A) | 3,90 % | 2.347.929 | -2,40 pp | |
| 09.05.2025 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | Passiv (13G) | 6,40 % | 3.806.867 | +1,40 pp | |
| 17.04.2025 | BlackRock, Inc. | Passiv (13G/A) | 8,30 % | 4.927.750 | Neu | |
| 07.03.2025 | ARK Investment Management LLC | Passiv (13G/A) | 10,70 % | 6.382.166 | +1,55 pp | |
| 12.02.2025 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | Passiv (13G/A) | 5,00 % | 2.949.723 | Neu | |
| 05.02.2025 | STATE STREET CORPORATION | Passiv (13G) | 4,30 % | 2.543.997 | Neu | |
| 10.01.2025 | ARK Investment Management LLC | Passiv (13G/A) | 9,15 % | 5.358.093 | -2,70 pp | |
| 08.11.2024 | Nikko Asset Management Americas, Inc. | Passiv (13G/A) | 4,88 % | 2.860.847 | -1,33 pp | |
| 08.11.2024 | Invesco Ltd. | Passiv (13G) | 6,30 % | 3.676.773 | Neu | |
| 05.11.2024 | Sumitomo Mitsui Trust Group, Inc. (“SMTG”) (+1) | Passiv (13G/A) | 4,88 % | 2.860.847 | Neu | |
| 09.08.2024 | JPMORGAN CHASE & CO. | Passiv (13G/A) | 4,30 % | 2.509.417 | -3,40 pp | |
| 09.07.2024 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 10,40 % | 6.068.671 | +4,00 pp | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 9,49 % | 5.475.322 | -0,53 pp | |
| 12.02.2024 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G) | 6,40 % | 3.723.305 | Neu | |
| 12.02.2024 | Nikko Asset Management Americas, Inc. | Passiv (13G/A) | 6,21 % | 3.583.443 | +1,03 pp | |
| 12.02.2024 | William Blair Investment Management, LLC | Passiv (13G) | 6,20 % | 3.549.874 | Neu | |
| 05.02.2024 | Sumitomo Mitsui Trust Holdings, Inc. (“SMTH”) (+1) | Passiv (13G/A) | 6,21 % | 3.583.443 | +1,03 pp | |
| 29.01.2024 | ARK | Passiv (13G/A) | 12,51 % | 7.213.257 | Neu | |
| 25.01.2024 | : STATE STREET CORPORATION | Passiv (13G/A) | 5,83 % | 0 | -1,99 pp | |
| 25.01.2024 | JPMORGAN CHASE & CO. | Passiv (13G/A) | 7,70 % | 4.462.494 | 0,00 pp | |
| 25.01.2024 | JPMORGAN CHASE & CO. | Passiv (13G/A) | 7,70 % | 4.462.494 | +1,00 pp | |
| 24.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 10,30 % | 5.946.345 | -0,60 pp | |
| 22.01.2024 | Integrated Core Strategies (US) LLC | Passiv (13G/A) | 2,70 % | 1.531.880 | -2,60 pp | |
| 22.01.2024 | Millennium Group Management LLC (+2) | Passiv (13G/A) | 3,20 % | 1.821.238 | -2,10 pp | |
| 08.09.2023 | Integrated Core Strategies (US) LLC | Passiv (13G) | 5,30 % | 3.042.960 | Neu | |
| 08.09.2023 | Millennium Group Management LLC (+2) | Passiv (13G) | 5,30 % | 3.045.913 | Neu | |
| 10.04.2023 | The Vanguard Group | Passiv (13G/A) | 10,02 % | 5.697.547 | +0,78 pp |
Finanzkennzahlen (SEC XBRL) ⓘ
Währung:
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | – | -44.021.000 $ | -0,71 $ | 676.214.000 $ | 455.094.000 $ |
| 2025-12-31 | 10-Q | – | -30.507.000 $ | -0,50 $ | 638.085.000 $ | 456.095.000 $ |
| 2025-12-31 | 10-Q/A | – | -30.507.000 $ | -0,50 $ | 638.085.000 $ | 456.095.000 $ |
| 2025-09-30 | 10-K | – | -77.670.000 $ | -1,30 $ | 641.861.000 $ | 472.958.000 $ |
| 2025-06-30 | 10-Q | – | 20.390.000 $ | 0,33 $ | 643.605.000 $ | 478.198.000 $ |
| 2025-03-31 | 10-Q | – | -39.328.000 $ | -0,66 $ | 595.615.000 $ | 440.108.000 $ |
| 2024-12-31 | 10-Q | – | -31.594.000 $ | -0,53 $ | 608.580.000 $ | 455.941.000 $ |
| 2024-12-31 | 10-Q/A | – | -31.594.000 $ | -0,53 $ | – | 455.941.000 $ |
| 2024-09-30 | 10-K | – | -208.726.000 $ | -3,60 $ | 614.323.000 $ | 472.689.000 $ |
| 2024-06-30 | 10-Q | – | -85.571.000 $ | -1,47 $ | 638.118.000 $ | 491.139.000 $ |
| 2024-03-31 | 10-Q | – | -45.492.000 $ | -0,79 $ | 702.846.000 $ | 560.131.000 $ |
| 2023-12-31 | 10-Q | – | -43.008.000 $ | -0,75 $ | 732.815.000 $ | 590.042.000 $ |
| 2023-09-30 | 10-K | – | -204.618.000 $ | -3,60 $ | 776.403.000 $ | 623.432.000 $ |
| 2023-06-30 | 10-Q | – | -57.395.000 $ | -1,01 $ | 810.332.000 $ | 657.550.000 $ |
| 2023-03-31 | 10-Q | – | -59.156.000 $ | -1,04 $ | 853.924.000 $ | 703.932.000 $ |
| 2022-12-31 | 10-Q | – | -41.824.000 $ | -0,74 $ | 909.970.000 $ | 746.325.000 $ |
| 2022-09-30 | 10-K | – | -217.863.000 $ | -4,04 $ | 961.378.000 $ | 789.385.000 $ |
| 2022-09-30 | 10-K/A | – | -217.863.000 $ | -4,04 $ | 961.378.000 $ | 789.385.000 $ |
| 2022-06-30 | 10-Q | – | -60.517.000 $ | -1,08 $ | 979.663.000 $ | 820.677.000 $ |
| 2022-03-31 | 10-Q | – | -60.668.000 $ | -1,13 $ | 1.021.636.000 $ | 863.361.000 $ |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Ngs Tools | 208,1 Mio. | 169,1 Mio. | 123,7 Mio. | 99,3 Mio. | 72,7 Mio. | 55,3 % | +23,0% | |
| Synthetic Genes | 113,6 Mio. | 92,7 Mio. | 73,5 Mio. | 61,5 Mio. | 39,0 Mio. | 30,2 % | +22,6% | |
| Antibody Discovery | 23,5 Mio. | 20,3 Mio. | 23,2 Mio. | 24,2 Mio. | – | 6,2 % | +15,4% | |
| Oligo Pools | 20,2 Mio. | 16,9 Mio. | 14,5 Mio. | 12,4 Mio. | 8,0 Mio. | 5,4 % | +19,7% | |
| Dna And Biopharma Libraries | 11,2 Mio. | 13,9 Mio. | 10,2 Mio. | 6,1 Mio. | 12,7 Mio. | 3,0 % | -19,7% |
Regionen
| Region | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Americas | 225,6 Mio. | 193,9 Mio. | 151,3 Mio. | 122,5 Mio. | 77,9 Mio. | 59,9 % | +16,3% | |
| EMEA | 124,2 Mio. | 92,6 Mio. | 71,4 Mio. | 62,1 Mio. | 44,1 Mio. | 33,0 % | +34,2% | |
| Asia Pacific | 26,8 Mio. | 26,5 Mio. | 22,5 Mio. | 19,0 Mio. | 10,3 Mio. | 7,1 % | +0,9% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q2 2026 | 31.03.2026 | 04.05.2026 | – | -0,71 |
| Q1 2025 | 31.12.2025 | 02.02.2026 | – | -0,50 |
| Q3 2025 | 30.06.2025 | 04.08.2025 | – | 0,33 |
| Q2 2025 | 31.03.2025 | 05.05.2025 | – | -0,66 |
| Q1 2024 | 31.12.2024 | 03.02.2025 | – | -0,53 |
| Q3 2024 | 30.06.2024 | 02.08.2024 | – | -1,47 |
| Q2 2024 | 31.03.2024 | 02.05.2024 | – | -0,79 |
| Q1 2023 | 31.12.2023 | 02.02.2024 | – | -0,75 |
| Q3 2023 | 30.06.2023 | 07.08.2023 | – | -1,01 |
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 04.05.2026 | 10-Q | 31.03.2026 | 34 Tage | SEC » |
| 26.02.2026 | 10-Q/A | 31.12.2025 | 57 Tage | SEC » |
| 02.02.2026 | 10-Q | 31.12.2025 | 33 Tage | SEC » |
| 17.11.2025 | 10-K | 30.09.2025 | 48 Tage | SEC » |
| 04.08.2025 | 10-Q | 30.06.2025 | 35 Tage | SEC » |
| 05.05.2025 | 10-Q | 31.03.2025 | 35 Tage | SEC » |
| 03.02.2025 | 10-Q | 31.12.2024 | 34 Tage | SEC » |
| 18.11.2024 | 10-K | 30.09.2024 | 49 Tage | SEC » |
| 02.08.2024 | 10-Q | 30.06.2024 | 33 Tage | SEC » |
| 02.05.2024 | 10-Q | 31.03.2024 | 32 Tage | SEC » |
| 02.02.2024 | 10-Q | 31.12.2023 | 33 Tage | SEC » |
| 21.11.2023 | 10-K | 30.09.2023 | 52 Tage | SEC » |
| 07.08.2023 | 10-Q | 30.06.2023 | 38 Tage | SEC » |
| 05.06.2023 | 10-K/A | 30.09.2022 | 248 Tage | SEC » |
| 08.05.2023 | 10-Q | 31.03.2023 | 38 Tage | SEC » |
| 07.02.2023 | 10-Q | 31.12.2022 | 38 Tage | SEC » |
| 28.11.2022 | 10-K | 30.09.2022 | 59 Tage | SEC » |
| 08.08.2022 | 10-Q | 30.06.2022 | 39 Tage | SEC » |
| 06.05.2022 | 10-Q | 31.03.2022 | 36 Tage | SEC » |
| 09.02.2022 | 10-Q | 31.12.2021 | 40 Tage | SEC » |
| 23.11.2021 | 10-K | 30.09.2021 | 54 Tage | SEC » |
| 09.08.2021 | 10-Q | 30.06.2021 | 40 Tage | SEC » |
| 07.05.2021 | 10-Q | 31.03.2021 | 37 Tage | SEC » |
| 09.02.2021 | 10-Q | 31.12.2020 | 40 Tage | SEC » |
| 27.11.2020 | 10-K | 30.09.2020 | 58 Tage | SEC » |
| 12.08.2020 | 10-Q | 30.06.2020 | 43 Tage | SEC » |
Kapitalerhöhungen & Emissions-Historie
Emissions-Historie aus den finalen SEC-Prospekten: Börsengang (424B4) und Kapitalerhöhungen (424B5, Folge-/Sekundärplatzierungen). Volumen = Brutto-Erlös (bei Börsengängen zusätzlich der Ausgabepreis). Wiederholte Kapitalerhöhungen deuten auf Verwässerung der Altaktionäre hin.
| Datum (US) | Art | Volumen | |
|---|---|---|---|
| 14.02.2022 | Kapitalerhöhung | – | SEC » |
| 09.02.2022 | Kapitalerhöhung | – | SEC » |
| 04.12.2020 | Kapitalerhöhung | – | SEC » |
| 01.12.2020 | Kapitalerhöhung | – | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Beträge in US-Dollar.
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | Form | |
|---|---|---|---|
| 06.01.2026 | HV-Einladung | DEF 14A | SEC » |
| 06.01.2025 | HV-Einladung | DEF 14A | SEC » |
| 26.12.2024 | Vorläufig | PRE 14A | SEC » |
| 05.01.2024 | HV-Einladung | DEF 14A | SEC » |
| 06.01.2023 | HV-Einladung | DEF 14A | SEC » |
| 04.01.2022 | HV-Einladung | DEF 14A | SEC » |
| 07.01.2021 | HV-Einladung | DEF 14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termine und Vergütung stehen im Dokument (SEC-Link).
Filing-Analyse (10-K / 10-Q)
Narrative-Analyse der letzten Quartals-/Jahresberichte durch Claude (nur Coverage-Gruppen-Mitglieder). Keine Anlageberatung — der qualitative Score dient der Einordnung, nicht als Kaufempfehlung; siehe allgemeiner Hinweis am Seitenende.
🔒 Die aufklappbare Detailanalyse (Red Flags, Risiko-Änderungen, Guidance-Zitate, voller Wortlaut) ist Teil des Kunden-Abos — freischalten.
| Datum | Form | Stimmung | Guidance | Risiko-Δ | Qualitativ | Zusammenfassung | |
|---|---|---|---|---|---|---|---|
| 02.02.2026 | 10-Q | 0,10 | k. A. | 0,00 | 40 | Twist Bioscience verzeichnete im ersten Quartal des Geschäftsjahres 2026 ein solides Umsatzwachstum von 16,9% auf 103,7 Mio. USD und eine verbesserte Bruttomarge von 52,0%, angetrieben durch Therapeutika- und Global-Supply-Partner-Segmente. Struktur… | 🔒 |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Tags | Schwere | Filing | Auszug |
|---|---|---|---|---|---|
| 06.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 11.02.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain officers… |
| 15.10.2024 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 05.01.2024 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 04.08.2023 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | forth by specific reference in such filing. Item 5.02 Departure of Directors or Certain Officers; Election of… |
| 23.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 28.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 26.10.2022 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 23.11.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 of the Original Report to include additional disclosure regarding a board committee assignment. This… |
| 09.08.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
8-K-Ereignisse (KI)
🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.
| Datum | Ereignis | Sentiment | Materialität | Zusammenfassung | Filing |
|---|---|---|---|---|---|
| 04.05.2026 | Quartalszahlen | 0,00 | 60 | Twist Bioscience gab am 4. Mai 2026 die Finanzierungsergebnisse für Q1 2026 (Quartal endend 31. März 2026) bekannt. Ohne Zugriff auf die vol… 🔒 | SEC |
| 17.02.2026 | Wesentliche Vereinbarung | 0,10 | 55 | Twist Bioscience gibt Aktienverkauf an Investoren ab 11. Februar 2026 durch Stock Purchase Agreements bekannt. Die Aktien werden als nicht-ö… 🔒 | SEC |
| 06.02.2026 | HV-Abstimmung | 0,10 | 20 | Twist Bioscience führte die jährliche Hauptversammlung mit 91,81% Quorum durch. Aktionäre stimmten über drei Anträge ab, einschließlich der … 🔒 | SEC |
| 02.02.2026 | Quartalszahlen | 0,00 | 60 | Twist Bioscience gab Finanzergebnisse für Q4 2025 (Ende 31. Dezember 2025) bekannt. Die Pressemitteilung wurde als Anlage eingereicht. | SEC |
| 12.01.2026 | Quartalszahlen | 0,00 | 65 | Twist Bioscience gab vorläufige, nicht auditierte Umsatzergebnisse für Q1 2026 bekannt. | SEC |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-06-12 | 515 | 74,05 | 38.136 |
| 2026-06-11 | 7 | 67,77 | 474 |
| 2026-06-10 | 74 | 70,06 | 5.184 |
| 2026-06-09 | 4.370 | 70,04 | 306.075 |
| 2026-06-08 | 6.419 | 69,22 | 444.323 |
| 2026-06-04 | 7 | 72,33 | 506 |
| 2026-06-02 | 623 | 67,86 | 42.277 |
| 2026-06-01 | 67 | 66,87 | 4.480 |
| 2026-05-27 | 6.093 | 64,87 | 395.253 |
| 2026-05-26 | 2.210 | 60,57 | 133.860 |
| 2026-05-19 | 595 | 49,79 | 29.625 |
| 2026-05-18 | 3.328 | 49,17 | 163.638 |